DaehanPharmaceutical Logo

DaehanPharmaceutical

Researches, develops, and manufactures human/animal pharma and bio-pharmaceuticals.

023910 | KO

Overview

Corporate Details

ISIN(s):
KR7023910003
LEI:
Country:
South Korea
Address:
서울특별시 영등포구 선유로45길 3, 서울특별시

Description

Daehan Nupharm is a pharmaceutical company engaged in the research, development, and manufacturing of a diverse portfolio of healthcare products. The company's business is structured around four core areas: human pharmaceuticals, offering a range of therapeutic treatments; animal health products for both companion and livestock animals; advanced bio-pharmaceuticals, with a focus on next-generation technologies like cell therapy; and health functional foods. Established initially in the animal health sector, the company leverages its dedicated Central and Bio Research Institutes to drive innovation and develop solutions for global markets. The R&D efforts concentrate on strengthening technological capabilities and advancing new treatment modalities.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-09 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-09-02 00:00
[기재정정]반기보고서 (2025.06)
Korean 840.3 KB
2025-09-01 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.1 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 816.8 KB
2025-07-29 00:00
주식등의대량보유상황보고서(약식)
Korean 121.1 KB
2025-05-27 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 770.8 KB
2025-04-21 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-04-11 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 26.7 KB
2025-04-04 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 26.7 KB
2025-04-02 00:00
주식등의대량보유상황보고서(약식)
Korean 174.0 KB
2025-03-26 00:00
정기주주총회결과
Korean 18.5 KB
2025-03-21 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 27.0 KB
2025-03-18 00:00
감사보고서제출
Korean 19.0 KB
2025-03-18 00:00
사업보고서 (2024.12)
Korean 956.2 KB

Automate Your Workflow. Get a real-time feed of all DaehanPharmaceutical filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DaehanPharmaceutical

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DaehanPharmaceutical via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.